According to Gram Research analysis, movement disorders occur in 25-50% of children with rare genetic seizure conditions called developmental and epileptic encephalopathies. Researchers identified 245 different genes causing these combined seizure and movement problems, with most affecting how nerve cells communicate. The most common movement problems are involuntary movements, muscle stiffness, and repetitive motions. Genetic testing can identify which specific gene is involved, allowing doctors to prescribe targeted treatments like specialized medications, ketogenic diet, or other precision therapies designed for that particular genetic cause.
A comprehensive review of research shows that children with developmental and epileptic encephalopathies—rare genetic conditions causing seizures and brain development issues—frequently experience movement disorders like involuntary movements, stiffness, or difficulty controlling their bodies. Scientists identified 245 different genes linked to these combined conditions and organized them into patterns to help doctors recognize and treat them better. The study reveals that movement problems occur in 25-50% of patients with these disorders and are often caused by problems with how nerve cells communicate. Understanding these genetic patterns is helping doctors develop more targeted treatments, from special diets to precision medicines designed for specific genetic mutations.
Key Statistics
A 2026 structured review in Movement Disorders Clinical Practice identified 245 single-gene associations with developmental and epileptic encephalopathies, with movement disorders occurring in approximately 25-50% of affected patients across multiple cohort studies.
Research shows that the majority of the 245 genes linked to seizure and movement disorder combinations affect ion channels or synaptic signaling pathways, the fundamental mechanisms controlling nerve cell communication in the brain.
A comprehensive analysis of eight cohort studies and multiple smaller series found that hyperkinetic movement disorders—including dystonia and stereotypies—are the most frequent movement problems in children with genetic seizure encephalopathies.
The 2026 review identified specific gene-symptom patterns, such as PRRT2 mutations causing infantile seizures with paroxysmal dyskinesia and SCN1A mutations producing Dravet syndrome with characteristic crouched gait abnormalities.
The Quick Take
- What they studied: How often children with rare genetic seizure disorders also have movement problems, what types of movement problems they have, and what genes cause these combined conditions.
- Who participated: The review analyzed data from eight large patient cohorts and multiple smaller studies involving children with developmental and epileptic encephalopathies—rare genetic brain conditions.
- Key finding: Movement disorders occur in roughly 25-50% of children with these rare seizure conditions, with involuntary movements and repetitive motions being most common. Researchers identified 245 different genes responsible for these combined disorders.
- What it means for you: If your child has a rare seizure disorder, doctors should screen for movement problems as part of routine care. Genetic testing can identify which specific gene is involved, which helps guide treatment choices including specialized diets, medications, or other therapies tailored to the genetic cause.
The Research Details
Researchers conducted a structured review of published medical literature to identify all known genetic causes of conditions where children have both seizures and movement disorders. They organized their findings into four categories based on study quality: large patient cohorts, small patient series, single-gene studies, and research focused on how genes work and potential treatments.
The team searched for patterns across these studies, grouping the 245 identified genes by how they function in the brain. Most genes affected either ion channels (structures that control electrical signals in nerve cells) or synaptic signaling (how nerve cells communicate with each other). They also organized clinical presentations into recognizable patterns: early-onset forms, late-onset forms, Rett syndrome and similar conditions, episodic disorders that come and go, severe acute worsening episodes, and progressive forms with increasing disability.
This approach allowed doctors to create a practical framework for recognizing these conditions in patients and matching them with appropriate treatments based on their specific genetic cause.
This systematic approach is important because these are rare conditions that individual doctors may see only occasionally. By organizing the genetic and clinical information into clear patterns, the review helps doctors recognize these disorders faster and more accurately. Understanding which genes are involved is crucial because it enables precision medicine—treatments specifically designed for the genetic cause rather than just treating symptoms generally.
This is a structured literature review, which means researchers systematically searched published medical literature rather than conducting a new experiment. The review included eight large cohort studies (groups of patients followed over time) plus multiple smaller studies, providing evidence from hundreds of patients. The identification of 245 single-gene associations demonstrates comprehensive coverage of the medical literature. However, because this is a review of existing studies rather than new research, the quality depends on the original studies reviewed. The authors acknowledge this is a non-systematic review, meaning they used structured methods but didn’t follow the most rigorous systematic review protocols.
What the Results Show
Movement disorders are common in children with developmental and epileptic encephalopathies, occurring in approximately 25-50% of patients across different studies. The most frequent movement problems are hyperkinetic disorders—meaning excessive or involuntary movements—including dystonia (sustained muscle contractions causing abnormal postures), stereotypies (repetitive, purposeless movements), and dyskinesia (involuntary writhing movements).
The research identified 245 different genes associated with these combined seizure and movement disorders. The vast majority of these genes affect either ion channels (which control electrical activity in nerve cells) or synaptic signaling pathways (how nerve cells communicate). This genetic diversity explains why these conditions present differently in different patients—the specific gene involved determines which symptoms appear and how severe they are.
Certain genetic patterns emerged consistently. For example, PRRT2 gene mutations cause infantile seizures combined with sudden episodes of involuntary movements. SCN1A mutations (which cause Dravet syndrome) produce seizures along with a characteristic crouched walking posture. Rett syndrome, caused by MECP2 mutations, features distinctive repetitive hand movements along with seizures and developmental regression.
The review organized these conditions into five clinical patterns: early infantile-onset forms, late infantile-onset forms, Rett and Rett-like syndromes, paroxysmal (sudden, episodic) disorders, and progressive hypokinetic forms (characterized by slowed movement and increasing disability).
Many patients experience multiple types of movement problems simultaneously rather than just one. This complexity reflects the underlying genetic and neurological dysfunction. The severity of movement disorders varies widely—some children have mild involuntary movements while others have severe, disabling movement problems that significantly impact quality of life. Some conditions feature sudden episodes of worsening movement problems (paroxysmal forms), while others show gradual progression over time. The review also noted that some conditions present with severe acute motor crises requiring emergency treatment, highlighting the need for specialized management approaches.
This review builds on decades of clinical observation by organizing scattered case reports and small studies into a comprehensive framework. Previous research identified individual gene-disorder associations, but this systematic approach reveals the broader patterns and common mechanisms. The identification of 245 genes represents a significant expansion from earlier understanding, reflecting advances in genetic testing technology over the past decade. The mechanistic grouping by ion channels and synaptic pathways aligns with current neuroscience understanding of how these genes cause disease.
This is a review of existing literature rather than new research, so findings depend on the quality and completeness of published studies. Some rare genetic forms may be underrepresented because they haven’t been published or are published in languages other than English. The review doesn’t provide detailed information about how common each specific genetic form is, making it difficult to predict which genes are most likely in a newly diagnosed patient. Treatment recommendations are based on limited evidence in many cases, as some genetic forms are so rare that large treatment studies aren’t possible. The review focuses on monogenic disorders (caused by a single gene mutation) and may not capture the full picture of movement disorders in children with more complex genetic causes.
The Bottom Line
For children diagnosed with developmental and epileptic encephalopathies: (1) Screen for movement disorders as part of standard evaluation—ask about involuntary movements, unusual postures, or difficulty with motor control. (2) Pursue comprehensive genetic testing including standard gene sequencing, copy number variant analysis, and repeat expansion testing to identify the specific genetic cause. (3) Once a genetic diagnosis is established, work with specialists to implement gene-informed treatments such as sodium-channel blockers for certain mutations, ketogenic diet (high-fat, low-carb), or other precision therapies. (4) Monitor for new or worsening movement problems, as some conditions feature episodic exacerbations requiring emergency intervention. Confidence level: Moderate to High for the importance of genetic testing and screening; Moderate for specific treatment recommendations as evidence varies by gene.
Parents and caregivers of children with rare seizure disorders should care about this research, as it directly impacts how their child’s condition is diagnosed and treated. Neurologists and pediatricians managing these children should use this framework to guide evaluation and treatment planning. Genetic counselors can use this information to explain to families why genetic testing is important. Researchers developing new treatments for rare neurological conditions should understand these genetic mechanisms. Children with undiagnosed seizure and movement disorders may benefit from genetic testing guided by this framework.
Genetic testing results typically arrive within 4-8 weeks. Once a genetic diagnosis is confirmed, some treatments (like ketogenic diet or specific medications) can begin within weeks, though benefits may take 2-4 weeks to become apparent. Other treatments like deep brain stimulation require months of planning and evaluation. Long-term management is ongoing, as some conditions are progressive and require periodic treatment adjustments. Families should expect this to be a long-term journey with gradual optimization of treatment rather than quick fixes.
Frequently Asked Questions
What are developmental and epileptic encephalopathies and why do they cause movement problems?
Developmental and epileptic encephalopathies are rare genetic conditions affecting brain development and function, causing seizures and often movement disorders. The genes involved control how nerve cells communicate and generate electrical signals. When these genes are mutated, both seizures and involuntary movements result from the same underlying brain dysfunction.
How common are movement disorders in children with rare seizure conditions?
Movement disorders occur in roughly 25-50% of children with developmental and epileptic encephalopathies, according to research reviewed across multiple patient cohorts. The specific type and severity vary depending on which gene is affected.
Can genetic testing help determine which treatment will work best for my child?
Yes. Identifying the specific gene mutation allows doctors to use precision medicine—treatments designed for that particular genetic cause. For example, sodium-channel blockers work for certain mutations, while ketogenic diet helps others. Genetic testing guides these targeted treatment decisions.
What types of movement problems do children with these conditions experience?
The most common are involuntary movements (dystonia, dyskinesia), repetitive motions (stereotypies), and abnormal postures. Many children experience multiple types simultaneously. Some have sudden episodes of worsening movements, while others show gradual progression over time.
Are there effective treatments for movement disorders in these genetic seizure conditions?
Treatment options include gene-informed medications (sodium-channel blockers, glutamatergic modulators), ketogenic diet, medications for episodic dyskinesias, and deep brain stimulation for severe cases. Effectiveness depends on the specific genetic cause, making genetic diagnosis essential for choosing appropriate therapy.
Want to Apply This Research?
- Track specific movement symptoms daily: record the type of involuntary movement (dystonia, stereotypy, dyskinesia), duration in minutes, time of day, any triggers (stress, fatigue, specific activities), and severity on a 1-10 scale. Also log seizure frequency and any medication changes.
- Work with your child’s doctor to establish a baseline of current movement symptoms, then use the app to monitor whether specific treatments (medication changes, diet modifications, or therapy) reduce symptom frequency or severity. Share weekly summaries with your medical team to guide treatment adjustments.
- Create a monthly report comparing movement symptom patterns to identify trends. Track which treatments correlate with improvement or worsening. Document any new symptoms or changes in existing patterns. Use this data during medical appointments to make evidence-based decisions about treatment modifications. Set reminders for medication administration and therapy sessions to ensure consistency.
This article reviews research on rare genetic conditions affecting seizures and movement. It is for educational purposes only and should not replace professional medical advice. If your child has seizures, movement problems, or developmental concerns, consult with a pediatric neurologist or geneticist for proper diagnosis and treatment. Genetic testing, medication decisions, and treatment plans must be individualized by qualified healthcare providers who can evaluate your child directly. The specific treatments mentioned (ketogenic diet, medications, deep brain stimulation) carry risks and benefits that must be discussed with your medical team. This review reflects published research as of 2026 and does not constitute medical advice for any individual case.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.